Poulton J, Deadman M E, Bronte-Stewart J, Foulds W S, Gardiner R M
Department of Paediatrics, University of Oxford, John Radcliffe Hospital, Headington.
J Med Genet. 1991 Nov;28(11):765-70. doi: 10.1136/jmg.28.11.765.
Twenty-eight patients from 25 maternal lineages with Leber's hereditary optic neuropathy (LHON) were investigated by restriction enzyme analysis for the presence or absence of the point mutation described by Wallace et al. The mutation was identified in 18 of 25 (72%) families with LHON. This provides further evidence that this mutation is present in the majority of patients with LHON. In 19 of these families with LHON, additional analysis using sequencing, oligonucleotide probing, and competitive oligonucleotide priming of PCR products was performed. In 14 cases with the site loss the point mutation was present, and five without the site loss had the wild type sequence in this region.
对来自25个母系血统的28例患有Leber遗传性视神经病变(LHON)的患者进行了限制性酶切分析,以检测是否存在Wallace等人描述的点突变。在25个LHON家族中的18个(72%)中鉴定出了该突变。这进一步证明该突变存在于大多数LHON患者中。在这些LHON家族中的19个中,使用测序、寡核苷酸探针和对PCR产物进行竞争性寡核苷酸引物延伸的方法进行了进一步分析。在14例有位点缺失的病例中存在点突变,5例没有位点缺失的病例在该区域具有野生型序列。